| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2019 | AMRN Amarin Corp Plc\uk | Kalb Michael Wayne | SVP And CFO | Sell | 50,000 | $19.67 | $983,270.00 | -70.6% | |
| Jul 1, 2019 | RMTI Rockwell Medical, Inc. | Paul Stuart M | Chief Executive Officer | Buy | 10,000 | $2.97 | $29,700.00 | +2.8% | |
| Jun 28, 2019 | ESPR Esperion Therapeutics, Inc. | Mayleben Timothy M | President &CEO | Buy | 5,000 | $46.00 | $230,000.00 | +8.2% | |
| Jun 28, 2019 | RMTI Rockwell Medical, Inc. | Smith Angus W. | Chief Financial Officer | Buy | 10,000 | $3.06 | $30,600.00 | +6.0% | |
| Jun 28, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 41,000 | $0.60 | $24,642.00 | - | |
| Jun 26, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 5,000 | $27.67 | $138,361.00 | -11.8% | |
| Jun 26, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 13,264 | $6.31 | $83,741.34 | -3.2% | |
| Jun 25, 2019 | MRK Merck & Co., Inc. | Davis Robert M46 | EVP, Global Svcs &CFO | Sell | 216,718 | $85.43 | $18,514,031.80 | -41.8% | |
| Jun 24, 2019 | AMRN Amarin Corp Plc\uk | Berg Aaron | Chief Commercial Officer | Sell | 113,195 | $18.59 | $2,104,521.44 | -75.7% | |
| Jun 20, 2019 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 14,340 | $27.89 | $399,934.90 | -1.1% | |
| Jun 20, 2019 | TLRY Tilray Brands, Inc. | Greenwood Maryscott | Director | Sell | 667 | $50.01 | $33,359.60 | -7.6% | |
| Jun 20, 2019 | TLRY Tilray Brands, Inc. | St.clare Christine | Director | Sell | 4,000 | $50.01 | $200,024.40 | -45.7% | |
| Jun 20, 2019 | TLRY Tilray Brands, Inc. | Dopp Rebekah | Director | Sell | 3,938 | $50.00 | $196,900.00 | -45.0% | |
| Jun 19, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 5,000 | $27.40 | $137,014.50 | -10.5% | |
| Jun 19, 2019 | LNTH Lantheus Holdings, Inc. | Bolla John J. | Chief Operations Officer | Sell | 1,747 | $27.56 | $48,148.98 | -2.3% | |
| Jun 19, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 8,876 | $6.22 | $55,187.13 | -1.9% | |
| Jun 19, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 32,000 | $0.63 | $20,071.00 | - | |
| Jun 18, 2019 | NBIX Neurocrine Biosciences Inc | Bozigian Haig P. | Chief Development Officer | Sell | 2,100 | $87.82 | $184,416.54 | -1.5% | |
| Jun 18, 2019 | AMRN Amarin Corp Plc\uk | Zakrzewski Joseph S55 | Director | Sell | 100,000 | $19.02 | $1,902,090.00 | -54.2% | |
| Jun 17, 2019 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 25,000 | $11.37 | $284,245.54 | -7.3% | |
| Jun 14, 2019 | ZTS Zoetis Inc. | Lewis Clinton A. Jr.46 | Executive Vice President | Sell | 6,123 | $109.79 | $672,244.17 | -12.4% | |
| Jun 13, 2019 | ZTS Zoetis Inc. | Reed Willie M55 | Director | Sell | 1,900 | $110.58 | $210,102.00 | -40.3% | |
| Jun 13, 2019 | NBIX Neurocrine Biosciences Inc | Bozigian Haig P. | Chief Development Officer | Sell | 17,268 | $82.62 | $1,426,627.81 | -5.7% | |
| Jun 12, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 5,000 | $25.27 | $126,365.00 | -9.5% | |
| Jun 12, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 21,640 | $6.28 | $135,951.29 | -1.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.